2023
Case Report: MR-LINAC-guided adaptive radiotherapy for gastric cancer
Song Y, Zhang Y, Wang H, Zhao M, Guan F, Li Z, Yue J. Case Report: MR-LINAC-guided adaptive radiotherapy for gastric cancer. Frontiers In Oncology 2023, 13: 1159197. PMID: 37746250, PMCID: PMC10514477, DOI: 10.3389/fonc.2023.1159197.Peer-Reviewed Original ResearchGastric cancerUpper abdomenGastric cancer patientsCourse of treatmentGastric cancer biopsiesDaily MR imageAdaptive radiotherapyMR-linacAdaptive treatment plansCT simulation imagesBlack stoolCancer patientsCase reportGastroscopy resultsInoperable tumorsPancreatic cancerImage-guided radiotherapyPatientsCancer biopsiesClinical experienceRadiotherapyTreatment planApparent causeCancerStomach
2022
Impact of dose calculation accuracy on inverse linear energy transfer optimization for intensity‐modulated proton therapy
Chen M, Cao W, Yepes P, Guan F, Poenisch F, Xu C, Chen J, Li Y, Vazquez I, Yang M, Zhu X, Zhang X. Impact of dose calculation accuracy on inverse linear energy transfer optimization for intensity‐modulated proton therapy. Precision Radiation Oncology 2022, 7: 36-44. DOI: 10.1002/pro6.1179.Peer-Reviewed Original ResearchIntensity-modulated proton therapyDose calculation accuracyMore beamsCalculation accuracyMC algorithmMonte Carlo algorithmDifferent dose calculation algorithmsTransfer optimizationProstate cancer patientsIntensity-modulated proton therapy (IMPT) plansProton therapyClinical target volumeNumber of beamsPencil beam algorithmDose calculation algorithmPlan robustnessDose calculation engineCarlo algorithmEnergy transfer optimizationFinal dose calculationInverse treatmentDose differenceCancer patientsProton therapy plansDose constraints
2019
Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization
Ge S, Wang X, Liao Z, Zhang L, Sahoo N, Yang J, Guan F, Mohan R. Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization. Cancers 2019, 11: 35. PMID: 30609652, PMCID: PMC6356681, DOI: 10.3390/cancers11010035.Peer-Reviewed Original ResearchLung cancer patientsIntensity-modulated proton therapyCancer patientsIMPT dose distributionsClinical target volume coverageNormal tissue dose distributionsTarget volume coveragePlanning target volumeTarget dose coverageConventional planning target volumeRespiratory motionDose distributionDifferent tumor sizesTarget dose distributionProton therapyTumor sizeLung cancerDose coverageTreatment planIMPT plansTarget volumeNormal tissuesVolume coverageRespiratory phasesPatients